This cross-sectional study describes the staging information obtained by prostate-specific membrane antigen–positron emission tomography/computed tomography (PSMA-PET/CT) among a patient cohort with high-risk biochemically recurrent prostate cancer with no metastatic disease found on conventional imaging. Here, FOLH1 is linked to metastatic neoplasm.